Objective To systematically evaluate the efficacy of traditional Chinese medicine / herbal decoction combined with ursodeoxycholic acid(UDCA) in the treatment of primary biliary cirrhosis(PBC),and to provide a reference for clinical medication.Methods Literature published before July 31,2014 was searched in databases as follows:Cochrane Library,Pub Med,China National Knowledge Infrastructure(CNKI),Chinese Scientific Journals Full-text Database(VIP),Chinese Biomedical Literature Database(CBM),and Wanfang Data.The randomized controlled trials(RCTs) comparing the efficacy of traditional Chinese medicine / herbal decoction combined with UDCA versus UDCA alone in PBC patients were included in the analysis.The methodological quality of included trials was assessed and the data were extracted,followed by meta-analysis using Rev Man 5.0 software.Results A total of 12 RCTs were included,involving 681 patients with 346 in the test group and 335 in the control group.The results of meta-analysis showed that,after 6 months of treatment,the overall response rate,improvement rate,and biochemical indices of liver function(ALT,ALP,GGT,and TBil) and hepatic fibrosis in the test group were significantly improved compared with those in the control group(all P < 0.05).There were no significant differences between the two groups in the immunological indices such as Ig A,Ig G,anti-mitochondrial antibody(AMA),and AMA M2 subtype(all P > 0.05).Conclusion Traditional Chinese medicine / herbal decoction combined with UDCA markedly improves the indices of hepatocellular necrosis and cholestasis,degree of hepatic fibrosis,and clinical symptoms in PBC patients after 6 months of treatment,but leads to no significant improvement in immunological indices.Due to the limited number of included RCTs and patients through systematic evaluation,and the presence of selection bias and publication bias,more double-blind randomized controlled trials with large sample size,multicenter involvement,and high quality are required to provide convincing evidence.
[1] | Wei YU, Chengbin ZHANG, Yan MA. A case of primary carcinosarcoma of the liver[J]. Journal of Clinical Hepatology, 2021, 37(12): 2890-2890. doi: 10.3969/j.issn.1001-5256.2021.12.030 |
[2] | Jiamin ZHAO, Zhiyuan CHEN, Chengliang DING, Lili YUAN, Jingjing QIAN, Chunyang XU, Lingyun ZUO. Primary biliary cholangitis with hepatic angiosarcoma: A case report[J]. Journal of Clinical Hepatology, 2021, 37(10): 2411-2413. doi: 10.3969/j.issn.1001-5256.2021.10.031 |
[3] | Mengnan LI, Gongchen WANG, Zhiming ZHANG. A case of hepatic angiosarcoma with Kasabach-Merritt syndrome[J]. Journal of Clinical Hepatology, 2021, 37(11): 2646-2648. doi: 10.3969/j.issn.1001-5256.2021.11.032 |
[4] | Huijun WANG, Jianxiang NIU, Xiaoyan XU, Weihua ZHENG, Pengfei LI, Yibo LIU, Junjing ZHANG. A case of primary splenic angiosarcoma[J]. Journal of Clinical Hepatology, 2021, 37(11): 2655-2657. doi: 10.3969/j.issn.1001-5256.2021.11.036 |
[5] | Li Dong, Luo TianYang, Ran YaWei. Value of contrast-enhanced computed tomography and magnetic resonance imaging in diagnosis of residual or recurrent lesion after transcatheter arterial chemoembolization in hepatocellular carcinoma:A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2214-2219. doi: 10.3969/j.issn.1001-5256.2019.10.017 |
[6] | Zhang XueWen, Dai ChaoLiu. Primary hepatic angiosarcoma in the elderly: A case report and literature review[J]. Journal of Clinical Hepatology, 2019, 35(3): 605-607. doi: 10.3969/j.issn.1001-5256.2019.03.031 |
[7] | Zhu XiXun, Li ZhiWei, Zheng Yu. A case of primary hepatic angiosarcoma with splenic metastasis and rupture[J]. Journal of Clinical Hepatology, 2019, 35(3): 608-610. doi: 10.3969/j.issn.1001-5256.2019.03.032 |
[8] | Wang ShuPeng, Han KaiZe, Wang Wu, Yang Yang, Liu YaHui. Spontaneous rupture of splenic angiosarcoma: 2 cases report[J]. Journal of Clinical Hepatology, 2018, 34(12): 2670-2671. doi: 10.3969/j.issn.1001-5256.2018.12.035 |
[9] | Huang Lu, Lu LiJian. CT and MRI manifestations of liver fluke granuloma[J]. Journal of Clinical Hepatology, 2017, 33(8): 1548-1551. doi: 10.3969/j.issn.1001-5256.2017.08.028 |
[10] | Du XiaoFeng, Ma ZhouPeng, Lin GuanSheng, He Hui, Tang YaRong, Wu JianMing. CT diagnosis and differentiation of nodular/mass-type hepatic lymphoma[J]. Journal of Clinical Hepatology, 2017, 33(8): 1492-1496. doi: 10.3969/j.issn.1001-5256.2017.08.016 |
[11] | Zhang YiWei, Zhang Wei, Liu Feng, Liu YaHui. Laparoscopic splenectomy in treatment of splenic angiosarcoma: a case report[J]. Journal of Clinical Hepatology, 2017, 33(4): 744-745. doi: 10.3969/j.issn.1001-5256.2017.04.034 |
[12] | Li XinMing, Quan XianYue, Tan ShuPing. Imaging feature of rare liver neoplasms[J]. Journal of Clinical Hepatology, 2016, 32(12): 2289-2294. doi: 10.3969/j.issn.1001-5256.2016.12.012 |
[13] | Zhai YaNan, Li Lei, Yin Liang, Guo QiHong, Lei JunQiang, Guo ShunLin, Zhang ChunYu, Wang HaiJun, Wen XiaoXiao. Role of dual-source CT low-dose whole liver perfusion imaging in evaluating liver blood perfusion after transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal hypertension[J]. Journal of Clinical Hepatology, 2016, 32(10): 1894-1899. doi: 10.3969/j.issn.1001-5256.2016.10.014 |
[14] | Ke JianJi, Liu FeiQi, Zhang Wei, Liu YaHui. One case of huge hepatic angiosarcoma[J]. Journal of Clinical Hepatology, 2015, 31(11): 1902-1903. doi: 10.3969/j.issn.1001-5256.2015.11.034 |
[15] | Liu BinBin, Wang YuHong. Values of MRI and CT in diagnosis and treatment of acute pancreatitis[J]. Journal of Clinical Hepatology, 2013, 29(7): 489-491. doi: 1001-5256 (2013) 07-0489-03 |
[16] | Yan FuHua, Luo XianFu. Research progress in CT and MR for quantitative diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2013, 29(10): 732-735. doi: 10.3969/j.issn.1001-5256.2013.10.003 |
[17] | Zhao ChunHua, Zhou WenFeng, Chen WeiHua, Xi Zhen, Zhang ChunMei. Clinical significance of α- fetoprotein in initial diagnosis of primary hepatic cancer[J]. Journal of Clinical Hepatology, 2013, 29(9): 698-701. doi: 10.3969/j.issn.1001-5256.2013.09.017 |
[18] | Liang Liang, Lu XiuLiang, Gu JunYing, Chen Gang, Rao ShengXiang, Ji Yuan, Ceng MengSu. Imaging characteristics of abdominal organs in autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2012, 28(8): 579-583. |
[19] | Liu Qin, Qiao XiuLi, Gao XiaoZhong, Shao ChunZhong. The importance of regular follow-up for early detection of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2010, 26(3): 306-307+309. |